For the quarter ending 2025-12-31, BTCY has $5,686,495 in assets. $38,208,764 in debts. $256,357 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash | 256,357 | 308,460 | 391,292 | |
| Accounts receivable, net | 1,578,269 | 2,099,065 | 1,860,715 | |
| Inventory note 3 | 1,974,758 | 2,256,289 | 1,783,426 | |
| Deposits and other receivables | 1,171,855 | 872,420 | 1,109,107 | |
| Total current assets | 4,981,239 | 5,536,234 | 5,144,540 | |
| Deposits and other receivables | 109,297 | 109,297 | 109,297 | |
| Long-term accounts receivable | 122,398 | 83,939 | 74,188 | |
| Property and equipment note 12 | 5,134 | 6,622 | 8,111 | |
| Operating right of use assets note 10 | 468,427 | 586,680 | 701,183 | |
| Total assets | 5,686,495 | 6,322,772 | 6,037,319 | |
| Accounts payable and accrued liabilities note 4 | 8,532,932 | 7,908,201 | 7,856,775 | |
| Convertible promissory notes and short term loans note 5 | 11,145,852 | 10,394,614 | 10,084,601 | |
| Term loan, current note 6 | 2,400,000 | 2,400,000 | 2,400,000 | |
| Derivative liabilities note 8 | 432,782 | 443,583 | 438,162 | |
| Advance from customers | 745,920 | 1,895,920 | 475,575 | |
| Operating lease obligations, current note 10 | 539,398 | 571,706 | 551,208 | |
| Total current liabilities | 23,796,884 | 23,614,024 | 21,806,321 | |
| Federally guaranteed loans note 7 | 870,800 | 870,800 | 870,800 | |
| Operating lease obligations | - | 102,307 | 252,172 | |
| Term loan note 6 | 12,130,104 | 12,015,626 | 12,425,131 | |
| Derivative liabilities note 8 | 1,410,976 | 1,382,103 | 1,481,522 | |
| Total liabilities | 38,208,764 | 37,984,860 | 36,835,946 | |
| Series b convertible redeemable preferred stock, 0.001 par value, 600 shares authorized as of september 30, 2025 and march 31, 2025, respectively, 360 and 385 shares issued and outstanding as of september 30, 2025 and march 31, 2025, respectively note 9-Series BConvertible Redeemable Preferred Stock | - | 1,750,290 | 2,000,290 | |
| Series b convertible redeemable preferred stock, 0.001 par value, 600 shares authorized as of december 31, 2025 and march 31, 2025, respectively, 335 and 385 shares issued and outstanding as of december 31, 2025 and march 31, 2025, respectively note 9 | 1,714,476 | - | - | |
| Series a preferred stock, 0.001 par value, 20,000 shares authorized as at december 31, 2025 and march 31, 2025, respectively, 201 preferred shares issued and outstanding as at december 31, 2025 and march 31, 2025, note 9 | 1 | 1 | 1 | |
| Common stock, 0.001 par value, 125,000,000 shares authorized as at december 31, 2025 and march 31, 2025, respectively. issued and outstanding common shares 27,807,711 and 26,081,295 as at december 31, 2025 and march 31, 2025, respectively, and exchangeable shares of 160,672 outstanding as at december 31, 2025 and march 31, 2025, respectively note 9 | 27,969 | 26,953 | 26,729 | |
| Shares to be issued 581,599 and 581,599 shares of common stock as at december 31, 2025 and march 31, 2025, respectively note 9 | 284,244 | 284,244 | 284,244 | |
| Additional paid-in-capital | 107,615,332 | 107,278,101 | 106,976,564 | |
| Accumulated other comprehensive loss | -47,823 | -33,276 | 109,623 | |
| Accumulated deficit | -142,116,468 | -140,968,401 | -140,196,078 | |
| Total stockholders (deficiency) | -34,236,745 | -33,412,378 | -32,798,917 | |
| Total liabilities, mezzanine and stockholders deficiency | 5,686,495 | 6,322,772 | 6,037,319 | |
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)